蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 288|回复: 4
收起左侧

[FDA药事] 咨询CFR211.186条款的理解

[复制链接]
药徒
发表于 2024-7-12 09:16:26 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
近期学习CFR211条款,211.186 Master production and control records.生产和控制主记录,其中有一条“应制订并遵循关于生产与控制主记录的准备操作的书面规程。”
这句话如何理解,或者需要做什么文件么?
有大神指导下,或者拉进FDA的交流群么
回复

使用道具 举报

药徒
发表于 2024-7-12 09:27:52 | 显示全部楼层

回帖奖励 +15 金币

我理解就是批生产包装检验记录 。批记录全生命周期的的管理规定。各公司应该都有批记录管理的文件吧
回复

使用道具 举报

药徒
发表于 2024-7-12 09:32:16 | 显示全部楼层
我的理解是,制定空白批记录的修订、发放、领用、传递的相关流程,确保批记录的流转受控。
回复

使用道具 举报

药生
发表于 2024-7-12 09:52:41 | 显示全部楼层
下次记得带英文一起发
§ 211.186 Master production and control records.

(a) To assure uniformity from batch to batch, master production and control records for each drug product, including each batch size thereof, shall be prepared, dated, and signed (full signature, handwritten) by one person and independently checked, dated, and signed by a second person. The preparation of master production and control records shall be described in a written procedure and such written procedure shall be followed.

(b) Master production and control records shall include:

(1) The name and strength of the product and a description of the dosage form;

(2) The name and weight or measure of each active ingredient per dosage unit or per unit of weight or measure of the drug product, and a statement of the total weight or measure of any dosage unit;

(3) A complete list of components designated by names or codes sufficiently specific to indicate any special quality characteristic;

(4) An accurate statement of the weight or measure of each component, using the same weight system (metric, avoirdupois, or apothecary) for each component. Reasonable variations may be permitted, however, in the amount of components necessary for the preparation in the dosage form, provided they are justified in the master production and control records;

(5) A statement concerning any calculated excess of component;

(6) A statement of theoretical weight or measure at appropriate phases of processing;

(7) A statement of theoretical yield, including the maximum and minimum percentages of theoretical yield beyond which investigation according to § 211.192 is required;

(8) A description of the drug product containers, closures, and packaging materials, including a specimen or copy of each label and all other labeling signed and dated by the person or persons responsible for approval of such labeling;

(9) Complete manufacturing and control instructions, sampling and testing procedures, specifications, special notations, and precautions to be followed.
回复

使用道具 举报

药徒
 楼主| 发表于 2024-7-14 10:38:36 | 显示全部楼层
chinsss 发表于 2024-7-12 09:52
下次记得带英文一起发
§ 211.186 Master production and control records.

中英文的标准都有,就是如何理解和具体操作这些要求。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2024-11-24 22:07

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表